Literature DB >> 11344230

The quantification of gluconeogenesis in healthy men by (2)H2O and [2-(13)C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-(13)C]glycerol.

M T Ackermans1, A M Pereira Arias, P H Bisschop, E Endert, H P Sauerwein, J A Romijn.   

Abstract

The quantification of gluconeogenesis (GNG) by (2)H2O and [2-(13)C]glycerol and the mass isotopomer dilution analysis of glucose does not involve assumptions regarding the enrichment of the oxaloacetate precursor pool. To compare these two methods we measured GNG in six healthy postabsorptive males under identical, strictly standardized, eucaloric conditions, once after oral administration of (2)H2O and once during a primed continuous infusion of [2-(13)C]glycerol. Endogenous glucose production (EGP) was measured by infusion of [6,6-(2)H(2)]glucose. EGP was not different after (2)H2O administration or during [2-(13)C]glycerol infusion (12.2 +/- 0.7 vs. 11.7 +/- 0.3 micromol/kg.min). However, GNG measured after (2)H2O administration was significantly higher than that during [2-(13)C]glycerol infusion (7.4 +/- 0.7 vs. 4.9 +/- 0.6 micromol/kg.min; P = 0.03), representing approximately 60% and 41% of EGP, respectively. The (2)H2O study was repeated during primed continuous infusion of unlabeled glycerol, showing that infusion of glycerol at the rate used in the [2-(13)C]glycerol method does not affect the measurement of GNG with (2)H2O, viz. 7.4 +/- 0.7 without glycerol vs. 7.6 +/- 0.9 micromol/kg.min with glycerol, representing approximately 60% vs. 62% of EGP. In conclusion, GNG measured by (2)H(2)O yields higher results than those measured by [2-(13)C]glycerol. This discrepancy is not merely caused by infusion of glycerol per se. Rather, the discrepancy between both methods probably relates to conceptual problems in underlying assumptions in one or both methods.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344230     DOI: 10.1210/jcem.86.5.7383

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

1.  Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.

Authors:  Elodie M Girault; Bruno Guigas; Anneke Alkemade; Ewout Foppen; Mariëtte T Ackermans; Susanne E la Fleur; Eric Fliers; Andries Kalsbeek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-05       Impact factor: 3.000

2.  Gluconeogenesis during endurance exercise in cyclists habituated to a long-term low carbohydrate high-fat diet.

Authors:  Christopher C Webster; Timothy D Noakes; Shaji K Chacko; Jeroen Swart; Tertius A Kohn; James A H Smith
Journal:  J Physiol       Date:  2016-06-08       Impact factor: 5.182

3.  Normal rates of whole-body fat oxidation and gluconeogenesis after overnight fasting and moderate-intensity exercise in patients with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  Hidde H Huidekoper; Mariëtte T Ackermans; René Koopman; Luc J C van Loon; Hans P Sauerwein; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

4.  Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.

Authors:  D H van Raalte; M Brands; N J van der Zijl; M H Muskiet; P J W Pouwels; M T Ackermans; H P Sauerwein; M J Serlie; M Diamant
Journal:  Diabetologia       Date:  2011-05-12       Impact factor: 10.122

5.  Meal timing effects on insulin sensitivity and intrahepatic triglycerides during weight loss.

Authors:  R I Versteeg; M T Ackermans; A J Nederveen; E Fliers; M J Serlie; S E la Fleur
Journal:  Int J Obes (Lond)       Date:  2017-08-16       Impact factor: 5.095

6.  Insulin resistance in obesity can be reliably identified from fasting plasma insulin.

Authors:  K W ter Horst; P W Gilijamse; K E Koopman; B A de Weijer; M Brands; R S Kootte; J A Romijn; M T Ackermans; M Nieuwdorp; M R Soeters; M J Serlie
Journal:  Int J Obes (Lond)       Date:  2015-07-09       Impact factor: 5.095

7.  Pituitary adenylate cyclase-activating polypeptide stimulates glucose production via the hepatic sympathetic innervation in rats.

Authors:  Chun-Xia Yi; Ning Sun; Mariette T Ackermans; Anneke Alkemade; Ewout Foppen; Jing Shi; Mireille J Serlie; Ruud M Buijs; Eric Fliers; Andries Kalsbeek
Journal:  Diabetes       Date:  2010-03-31       Impact factor: 9.461

8.  A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type 1a and fructose-1,6-bisphosphatase deficiency.

Authors:  Hidde H Huidekoper; Gepke Visser; Mariëtte T Ackermans; Hans P Sauerwein; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2010-02-02       Impact factor: 4.982

9.  Omega-3 long-chain fatty acids strongly induce angiopoietin-like 4 in humans.

Authors:  Myrte Brands; Hans P Sauerwein; Mariette T Ackermans; Sander Kersten; Mireille J Serlie
Journal:  J Lipid Res       Date:  2013-01-14       Impact factor: 5.922

10.  Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver.

Authors:  Lars P Klieverik; Sarah F Janssen; Annelieke van Riel; Ewout Foppen; Peter H Bisschop; Mireille J Serlie; Anita Boelen; Mariëtte T Ackermans; Hans P Sauerwein; Eric Fliers; Andries Kalsbeek
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.